{"id":116395,"date":"2009-10-22T00:00:00","date_gmt":"2009-10-22T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/report\/hpdasdnlfa09-marketaccess-new-england-fall-2009-health-plan-analysis\/"},"modified":"2009-10-22T00:00:00","modified_gmt":"2009-10-22T00:00:00","slug":"hpdasdnlfa09-marketaccess-new-england-fall-2009-health-plan-analysis","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/hpdasdnlfa09-marketaccess-new-england-fall-2009-health-plan-analysis\/","title":{"rendered":"New England | Fall | 2009 | Health Plan Analysis"},"content":{"rendered":"<p>Massachusetts&#039; largest health insurer, Blue Cross Blue Shield, is embracing one of the latest trends in pharmacy benefit management, that of value-based benefit design. The Boston-based health plan, already the only state HMO offering the design to self-insured accounts, will become the first HMO in Massachusetts to offer a VBBD to the fully insured group market beginning Jan. 1, 2010. Also embracing the VBBD concept is the state of Maine, which is seeing a strong return on investment from its VBBD program revolving around diabetes for state employees. The strong results prompted the state to expand to new disease states. Meanwhile, a growing concern for health insurers across New England is rising costs of specialty drugs, prompting heatlh plans to implement a variety of strategies to control those costs. In Massachusetts, Bay State officials have been working to keep its landmark near-universal healthcare reform afloat amidst severe economic turmoil. A $5.4 billion state deficit and tax collections down by almost $3 billion forced state officials to institute cutbacks to the state&#039;s reform, shifting around 31,000 legal immigrants to a less generous\u2014and less costly\u2014benefit.<\/p>\n","protected":false},"template":"","class_list":["post-116395","report","type-report","status-publish","hentry","report-gateway-marketaccess","marketaccess-product-health-plan-data-analysis","marketaccess-state-maine","marketaccess-state-massachusetts","marketaccess-state-new-hampshire","marketaccess-state-rhode-island","marketaccess-state-vermont","marketaccess-date-549"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/116395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":0,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/116395\/revisions"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=116395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}